EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC-ND 4.0

Comparison Between MAIA and MP-3 In Healthy Subjects and Patients With Diabetes, Diabetic Retinopathy, and Age-Related Macular Degeneration

Anna Marmalidou, Haleema Siddiqui, Muhammad Usman Jamil, Kwang Min Woo, Antonio Yaghy, A Yasin Alibhai, Hiroyuki Takahashi, Stephanie Kaiser, Keith Effert, Peter Y Zhao, Shilpa J Desai, Christopher C Robinson und 2 weitere

Investigative Ophthalmology & Visual Science · 2025

DOI: 10.1167/iovs.66.3.59 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Investigative Ophthalmology & Visual Science, 2025. Verfasst von Anna Marmalidou und 13 weiteren Autor:innen. Beteiligte Einrichtung: New England Eye Center, Department of Ophthalmology, Tufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts, United States. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Macular Degeneration, Diabetes Mellitus, Visual Field Tests. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The purpose of this study was to assess the comparability of mean sensitivity (MS) values obtained using the Macular Integrity Assessment (MAIA; CenterVue S.p.A. [iCare], Padova, Italy) and Microperimeter-3 (MP-3; NIDEK CO., Ltd., Gamagori, Japan) microperimetry (MP) devices.

Methods

This cross-sectional study includes subjects with healthy eyes, eyes with diabetes mellitus without diabetic retinopathy (DM no DR), diabetic retinopathy (DR), and non-exudative age-related macular degeneration (AMD). Patients underwent testing on both MAIA and MP-3 MP devices, using a 10-2 macular grid with 68 stimuli and identical parameters. A diagnosis-adjusted linear regression model and mixed modeling mapped MP-3 MS to MAIA MS and Bland-Altman analysis were used to assess the agreement.

Results

One hundred eleven eyes (43 healthy eyes, 14 eyes with DM no DR, 32 eyes with DR, and 22 eyes with AMD) from 80 subjects (age = 57.2 ± 20.3 years) were enrolled. MAIA consistently showed higher MS than MP-3. The MP-3 device detected absolute scotomatous points in more eyes than MAIA (6 eyes [MAIA] vs. 10 eyes [MP-3]). Healthy eyes exhibited stronger agreements than those with DR (P < 0.001) or AMD (P = 0.015). Converting MP-3 to MAIA MS improved agreement and reduced coefficients of repeatability (CoRs) but did not fully account for inter-device variability. MP-3 classified more eyes as having relatively unstable or unstable fixation than MAIA (P = 0.014).

Conclusions

Both devices effectively detect retinal functional changes and scotomas. The conversion methods developed in this study can aid cross-device comparisons, but retinal pathologies (DM and AMD) introduce additional inter-device variability. Future studies incorporating multiple devices should account for this variability in their study design.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic RetinopathyMacular DegenerationDiabetes MellitusVisual Field TestsScotomaHealthy VolunteersCross-Sectional StudiesMacula LuteaLinear ModelsHumansMaleFemaleAdultMiddle AgedAgedFundus OculiYoung AdultAged, 80 and overVisual Fields

Autor:innen und Institutionen

  • New England Eye Center, Department of Ophthalmology, Tufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts, United States.
  • Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, United States.
  • Boston Image Reading Center, Boston, Massachusetts, United States.
  • Department of Ophthalmology and Visual Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
  • Nidek Inc., San Jose, California, United States.

Zitieren

APA

Marmalidou, A., Siddiqui, H., Jamil, M. U., Woo, K. M., Yaghy, A., Alibhai, A. Y., Takahashi, H., Kaiser, S., Effert, K., Zhao, P. Y., Desai, S. J., Robinson, C. C., Duker, J. S., & Waheed, N. K. (2025). Comparison Between MAIA and MP-3 In Healthy Subjects and Patients With Diabetes, Diabetic Retinopathy, and Age-Related Macular Degeneration. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.66.3.59

Vancouver

Marmalidou A, Siddiqui H, Jamil MU, Woo KM, Yaghy A, Alibhai AY, et al. Comparison Between MAIA and MP-3 In Healthy Subjects and Patients With Diabetes, Diabetic Retinopathy, and Age-Related Macular Degeneration. Investigative Ophthalmology & Visual Science. 2025. doi:10.1167/iovs.66.3.59

BibTeX
@article{Marmalidou2025,
  author = {Marmalidou, Anna and Siddiqui, Haleema and Jamil, Muhammad Usman and Woo, Kwang Min and Yaghy, Antonio and Alibhai, A Yasin and Takahashi, Hiroyuki and Kaiser, Stephanie and Effert, Keith and Zhao, Peter Y and Desai, Shilpa J and Robinson, Christopher C and Duker, Jay S and Waheed, Nadia K},
  title = {Comparison Between MAIA and MP-3 In Healthy Subjects and Patients With Diabetes, Diabetic Retinopathy, and Age-Related Macular Degeneration},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2025},
  doi = {10.1167/iovs.66.3.59}
}
Kostenlos starten →